SEPTEMBER - 20225TECH OUTLOOKIN MY OPINIONCOMPANY OF THE YEARLAST WORD38C O NT E NT SOlga Minkov, Executive Director, Operations ­ Pharmacovigilance & Epi., Gilead Sciences [NASDAQ:GILD]How CMOs/CDMOs can Add Value for Pharma CompaniesOzgur Akbulut, Director, Global Divestments and Contract Manufacturing Lead, Takeda [NYSE:TAK]08Managing Impacts of Technology Transformations in PharmacovigilanceTOP 10CONTRACT MANUFACTURINGORGANIZATIONS - 2022ABL, an Institut Mérieux CompanyPatrick Mahieux,General Manager, ABL Europe21Ascendia PharmaceuticalsJim Huang,Founder and CEO22AstaTechDr. Shan Jiang, BD Manager26Aspen APIDavid Demailly, API Commercial Director25Center for Breakthrough MedicinesJoerg Ahlgrimm,President and CEO28Goodwin BiotechnologyDarrin T. Schellin,Chief Executive Officer30TeleTec ElectronicsTerrence Chou, Founder and CEO32TCG GreenChem Inc.,18Joe Armstrong, COO and Head of Business Development at TCG GreenChem IncDr. Chris H. Senanayake, Founder, CEO, andCSO of TCG GreenChem
< Page 4 | Page 6 >